Skip to content

Eli Lilly

NYSE: LLY · USD

Eli Lilly cash flow and EPS84

Operating cash flow, capital investment, free cash flow and earnings per share.

Capital allocation

% of tracked cash uses

$4,020M
Eli Lilly capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2009 Q2UnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FY 2009 Q3UnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FY 2009 Q4Unavailable0% · $0MUnavailable90.4% · $3,764.5M9.6% · $400M100% · $4,164.5M
FY 2010 Q1UnavailableUnavailableUnavailable100% · $539.2M0% · $0M100% · $539.2M
FY 2010 Q2UnavailableUnavailableUnavailable100% · $536.7MUnavailable100% · $536.7M
FY 2010 Q3Unavailable24.8% · $180.3MUnavailable75.01% · $545.3M0.19% · $1.4M100% · $727M
FY 2010 Q4Unavailable34.02% · $280.7MUnavailable65.94% · $544.1M0.05% · $0.4M100% · $825.2M
FY 2011 Q1Unavailable0% · $0MUnavailable90.87% · $543.2M9.13% · $54.6M100% · $597.8M
FY 2011 Q2Unavailable0% · $0MUnavailable100% · $552.1M0% · $0M100% · $552.1M
FY 2011 Q3Unavailable36.27% · $307.8MUnavailable63.73% · $540.9M0% · $0M100% · $848.7M
FY 2011 Q4Unavailable0% · $0MUnavailable100% · $543.9M0% · $0M100% · $543.9M
FY 2012 Q1Unavailable8.72% · $195.4M0% · $0M24.31% · $544.6M66.96% · $1,500M100% · $2,240M
FY 2012 Q2Unavailable0.7% · $3.9M0% · $0M99.3% · $550.4M0% · $0M100% · $554.3M
FY 2012 Q3Unavailable0% · $0M0% · $0M100% · $544.2M0% · $0M100% · $544.2M
FY 2012 Q4Unavailable0% · $0M56.78% · $721.1M43.17% · $548.2M0.05% · $0.6M100% · $1,269.9M
FY 2013 Q1Unavailable0% · $0M69.25% · $1,198.1M30.7% · $531.1M0.05% · $0.9M100% · $1,730.1M
FY 2013 Q2Unavailable0% · $0M0% · $0M99.85% · $533M0.15% · $0.8M100% · $533.8M
FY 2013 Q3Unavailable7.63% · $43.7M0% · $0M92.14% · $527.7M0.23% · $1.3M100% · $572.7M
FY 2013 Q4Unavailable0% · $0M48.24% · $500M51.03% · $528.9M0.72% · $7.5M100% · $1,036.4M
FY 2014 Q1Unavailable0% · $0M3.48% · $55M33.15% · $524.1M63.37% · $1,002M100% · $1,581.1M
FY 2014 Q2Unavailable43.93% · $551.4M11.55% · $145M41.98% · $526.9M2.53% · $31.8M100% · $1,255.1M
FY 2014 Q3Unavailable0% · $0M36.34% · $300M63.6% · $525M0.06% · $0.5M100% · $825.5M
FY 2014 Q4Unavailable0% · $0M36.33% · $300M63.61% · $525.2M0.06% · $0.5M100% · $825.7M
FY 2015 Q1Unavailable86.27% · $5,276.7M5.08% · $310.6M8.63% · $527.9M0.02% · $1.5M100% · $6,116.7M
FY 2015 Q2Unavailable0% · $0M4.78% · $124.9M20.64% · $539.8M74.58% · $1,950M100% · $2,614.7M
FY 2015 Q3Unavailable1.85% · $11.1M10.19% · $61.1M87.73% · $526.3M0.23% · $1.4M100% · $599.9M
FY 2015 Q4UnavailableUnavailable31.96% · $252.9M67.4% · $533.3M0.64% · $5.1M100% · $791.3M
FY 2016 Q1Unavailable0% · $0M35.79% · $300.1M64.21% · $538.3M0% · $0M100% · $838.4M
FY 2016 Q2Unavailable7.68% · $45M0% · $0M92.31% · $541.2M0.02% · $0.1M100% · $586.3M
FY 2016 Q3Unavailable0% · $0M0% · $0M99.98% · $537.9M0.02% · $0.1M100% · $538M
FY 2016 Q4Unavailable0% · $0M9.98% · $60M90.02% · $541.1M0% · $0M100% · $601.1M
FY 2017 Q1Unavailable42.83% · $882.1M0% · $0M26.58% · $547.4M30.6% · $630.2M100% · $2,059.7M
FY 2017 Q2Unavailable0% · $0M26.69% · $199.9M73.27% · $548.7M0.04% · $0.3M100% · $748.9M
FY 2017 Q3Unavailable0% · $0M0% · $0M99.98% · $547.7M0.02% · $0.1M100% · $547.8M
FY 2017 Q4Unavailable0% · $0M15.41% · $99.9M84.59% · $548.3M0% · $0M100% · $648.2M
FY 2018 Q1Unavailable0% · $0M44.22% · $1,100M23.61% · $587.3M32.17% · $800.3M100% · $2,487.6M
FY 2018 Q2Unavailable0% · $0M54.92% · $950.7M33.46% · $579.3M11.62% · $201.2M100% · $1,731.2M
FY 2018 Q3Unavailable0% · $0M63.59% · $1,000M36.41% · $572.6M0% · $0M100% · $1,572.6M
FY 2018 Q4Unavailable0% · $0M65.47% · $1,100M34.08% · $572.6M0.45% · $7.6M100% · $1,680.2M
FY 2019 Q11.72% · $203.7M58.33% · $6,917.7M29.51% · $3,500M5.37% · $637.2M5.06% · $600M100% · $11,858.6M
FY 2019 Q228.66% · $240.3M0% · $0M0% · $0M71.32% · $598M0.02% · $0.2M100% · $838.5M
FY 2019 Q318.15% · $263.4M0% · $0M41.35% · $600M40.49% · $587.4M0.01% · $0.1M100% · $1,450.9M
FY 2019 Q4Unavailable0% · $0M9.51% · $300M18.62% · $587.2M71.86% · $2,266.1M100% · $3,153.3M
FY 2020 Q110.11% · $258.3M33.24% · $849.3M19.57% · $500M26.27% · $671.3M10.81% · $276.3M100% · $2,555.2M
FY 2020 Q229.48% · $281.8M0% · $0M0% · $0M70.52% · $674.2M0% · $0M100% · $956M
FY 2020 Q336.92% · $393.1M0% · $0M0% · $0M63.08% · $671.6M0% · $0M100% · $1,064.7M
FY 2020 Q4Unavailable0% · $0M0% · $0M99.97% · $670M0.03% · $0.2M100% · $670.2M
FY 2021 Q116.48% · $300.3M41.01% · $747.4M0% · $0M42.51% · $774.8M0% · $0M100% · $1,822.5M
FY 2021 Q223.11% · $381.3M0% · $0M30.31% · $500M46.57% · $768.3M0% · $0M100% · $1,649.6M
FY 2021 Q311.18% · $336.8M0% · $0M0% · $0M25.57% · $770.4M63.25% · $1,905.3M100% · $3,012.5M
FY 2021 Q4Unavailable0% · $0M49.23% · $750M50.76% · $773.3M0.01% · $0.1M100% · $1,523.4M
FY 2022 Q110.56% · $365.4M0% · $0M43.34% · $1,500M25.59% · $885.5M20.52% · $710.1M100% · $3,461M
FY 2022 Q217.63% · $371M0% · $0M0% · $0M41.99% · $883.7M40.38% · $849.9M100% · $2,104.6M
FY 2022 Q341.16% · $617.2M0% · $0M0% · $0M58.84% · $882.2M0% · $0M100% · $1,499.4M
FY 2022 Q4Unavailable27.01% · $327.2M0% · $0M72.99% · $884.4M0% · $0M100% · $1,211.6M
FY 2023 Q1UnavailableUnavailable42.44% · $750M57.56% · $1,017.2M0% · $0M100% · $1,767.2M
FY 2023 Q2UnavailableUnavailable0% · $0M100% · $1,017.8M0% · $0M100% · $1,017.8M
FY 2023 Q3UnavailableUnavailable0% · $0M100% · $1,016.2M0% · $0M100% · $1,016.2M
FY 2023 Q4UnavailableUnavailable0% · $0M100% · $1,018.1M0% · $0M100% · $1,018.1M
FY 2024 Q1UnavailableUnavailable0% · $0M100% · $1,169.2MUnavailable100% · $1,169.2M
FY 2024 Q2UnavailableUnavailable0% · $0M100% · $1,172.4MUnavailable100% · $1,172.4M
FY 2024 Q3UnavailableUnavailable27.59% · $446.1M72.41% · $1,170.5M0% · $0M100% · $1,616.6M
FY 2024 Q4UnavailableUnavailable63.74% · $2,053.9M36.26% · $1,168.3M0% · $0M100% · $3,222.2M
FY 2025 Q1UnavailableUnavailable47.13% · $1,200M52.87% · $1,346.3M0% · $0M100% · $2,546.3M
FY 2025 Q2UnavailableUnavailable24.57% · $692.2M47.81% · $1,347M27.62% · $778.1M100% · $2,817.3M
FY 2025 Q3UnavailableUnavailable34.49% · $708.1M65.51% · $1,345.2M0% · $0M100% · $2,053.3M
FY 2025 Q4UnavailableUnavailable52.84% · $1,507.7M47.16% · $1,345.5MUnavailable100% · $2,853.2M
FY 2026 Q1UnavailableUnavailable50.62% · $2,356M33.26% · $1,548M16.12% · $750M100% · $4,654M
FY 2026 Q2UnavailableUnavailable39.83% · $1,601M38.46% · $1,546M21.72% · $873M100% · $4,020M
Jun 30, 2009 through Jun 30, 2026

Operating cash flow

USD millions

$10,690M

Capital expenditures

USD millions

—

Free cash flow

USD millions

—

Stock-based compensation

USD millions

$201M

SBC / free cash flow

% · FCF before SBC deduction

—

SBC / operating cash flow

%

1.88%

Software & intangible investment

USD millions

—

Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.

Diluted EPS

USD per share

$7.94

Quarterly data

Eli Lilly cash-flow history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal periodEndedOperating cash flowUSD millionsCapital expendituresUSD millionsFree cash flowUSD millionsStock-based compensationUSD millionsSBC / free cash flow%SBC / operating cash flow%Software & intangible investmentUSD millionsDiluted EPSUSD per share
FY 2026 Q2Jun 30, 202610,690——201—1.88%—$7.94
FY 2026 Q1Mar 31, 20265,333——161—3.02%—$8.26
FY 2025 Q4Dec 31, 20253,224.6——136.1—4.22%——
FY 2025 Q3Sep 30, 20258,835.9——151.1—1.71%—$6.21
FY 2025 Q2Jun 30, 20253,086.9——185.1—6%—$6.29
FY 2025 Q1Mar 31, 20251,665.6——153.7—9.23%—$3.06
FY 2024 Q4Dec 31, 20242,473.8——141.9—5.74%——
FY 2024 Q3Sep 30, 20243,711.9——133.2—3.59%—$1.07
FY 2024 Q2Jun 30, 20241,466.2——211.1—14.4%—$3.28
FY 2024 Q1Mar 31, 20241,166——159.4—13.67%—$2.48
FY 2023 Q4Dec 31, 2023-311.9——120.2————
FY 2023 Q3Sep 30, 20232,189.5——215.6—9.85%—$-0.06
FY 2023 Q2Jun 30, 2023631.9——161.5—25.56%—$1.95
FY 2023 Q1Mar 31, 20231,730.6——131.2—7.58%—$1.49
FY 2022 Q4Dec 31, 20221,579.7——92.9—5.88%——
FY 2022 Q3Sep 30, 20222,184.8617.21,567.685.15.43%3.9%—$1.61
FY 2022 Q2Jun 30, 2022820.7371449.792.120.48%11.22%—$1.05
FY 2022 Q1Mar 31, 20222,499.2365.42,133.81014.73%4.04%—$2.1
FY 2021 Q4Dec 31, 20212,156.5——75.3—3.49%——
FY 2021 Q3Sep 30, 20211,631.3336.81,294.590.16.96%5.52%—$1.22
FY 2021 Q2Jun 30, 20211,775.5381.31,394.291.96.59%5.18%—$1.53
FY 2021 Q1Mar 31, 20211,697.4300.31,397.185.56.12%5.04%—$1.49
FY 2020 Q4Dec 31, 20201,815.2——87.8—4.84%——
FY 2020 Q3Sep 30, 20201,806.6393.11,413.571.75.07%3.97%—$1.33
FY 2020 Q2Jun 30, 20202,495.4281.82,213.676.83.47%3.08%—$1.55
FY 2020 Q1Mar 31, 2020382.4258.3124.171.857.86%18.78%—$1.6
FY 2019 Q4Dec 31, 20191,963.7——81.6—4.16%—$1.64
FY 2019 Q3Sep 30, 20191,510.1263.41,246.775.56.06%5%—$1.37
FY 2019 Q2Jun 30, 20191,051.5240.3811.279.59.8%7.56%—$1.44
FY 2019 Q1Mar 31, 2019311.3203.7107.675.870.45%24.35%—$4.31
FY 2018 Q4Dec 31, 20181,448.7——72.8—5.03%—$1.1
FY 2018 Q3Sep 30, 20182,121.8——68.5—3.23%—$1.12
FY 2018 Q2Jun 30, 20181,517.5——70.2—4.63%—$-0.25
FY 2018 Q1Mar 31, 2018436.5——68—15.58%—$1.16
FY 2017 Q4Dec 31, 20171,743.5——72.2—4.14%—$-1.58
FY 2017 Q3Sep 30, 20171,881.1——69.9—3.72%—$0.53
FY 2017 Q2Jun 30, 20171,651.1——69.9—4.23%—$0.95
FY 2017 Q1Mar 31, 2017339.9——69.3—20.39%—$-0.1
FY 2016 Q4Dec 31, 20162,116.9——66.8—3.16%—$0.73
FY 2016 Q3Sep 30, 20161,659.2——61.5—3.71%—$0.73
FY 2016 Q2Jun 30, 20161,401.8——65—4.64%—$0.71
FY 2016 Q1Mar 31, 2016-326.9——62———$0.41
FY 2015 Q4Dec 31, 2015804.3——58.4—7.26%—$0.45
FY 2015 Q3Sep 30, 20151,104.7——54.7—4.95%—$0.75
FY 2015 Q2Jun 30, 2015948.6——55.8—5.88%—$0.56
FY 2015 Q1Mar 31, 2015-84.8——48.9———$0.5
FY 2014 Q4Dec 31, 20141,349.6——40.6—3.01%—$0.4
FY 2014 Q3Sep 30, 20141,691.3——38.5—2.28%—$0.47
FY 2014 Q2Jun 30, 20141,053.9——38.6—3.66%—$0.68
FY 2014 Q1Mar 31, 2014272.3——38.3—14.07%—$0.68
FY 2013 Q4Dec 31, 20131,726.8——39.8—2.3%—$0.67
FY 2013 Q3Sep 30, 20131,991.6——36.3—1.82%—$1.11
FY 2013 Q2Jun 30, 20131,637.2——33.6—2.05%—$1.11
FY 2013 Q1Mar 31, 2013379.4——35.2—9.28%—$1.42
FY 2012 Q4Dec 31, 20121,602——41.2—2.57%—$0.74
FY 2012 Q3Sep 30, 20121,544.3——34.5—2.23%—$1.18
FY 2012 Q2Jun 30, 20121,306——37.6—2.88%—$0.83
FY 2012 Q1Mar 31, 2012852.5——28.2—3.31%—$0.91
FY 2011 Q4Dec 31, 20111,944.7——36.7—1.89%——
FY 2011 Q3Sep 30, 20112,073.4——36.5—1.76%—$1.11
FY 2011 Q2Jun 30, 20112,040.3——36.3—1.78%—$1.07
FY 2011 Q1Mar 31, 20111,176.1——37.9—3.22%—$0.95
FY 2010 Q4Dec 31, 20102,228.1——55.8—2.5%——
FY 2010 Q3Sep 30, 20101,759.1——303.4—17.25%—$1.18
FY 2010 Q2Jun 30, 20101,911.6——-54.5—-2.85%—$1.22
FY 2010 Q1Mar 31, 2010958——-73.7—-7.69%—$1.13
FY 2009 Q4Dec 31, 20092,018.6——-632.9—-31.35%——
FY 2009 Q3Sep 30, 20091,305.7——104—7.97%——
FY 2009 Q2Jun 30, 2009923.3——226.5—24.53%——
Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

FCF subtracts reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Acquisitions and noncash lease additions are excluded. EPS and weighted shares are not summed across quarters. Annual figures use annual reports.

SBC / FCF always uses FCF before SBC deduction; both SBC ratios compare amounts from the same period. A zero or negative cash-flow denominator is undefined, and values above 100% are retained.

Each reported nonnegative cash use / sum of available tracked nonnegative cash uses × 100. Missing categories are omitted, never set to zero. This is the composition of tracked uses, not a complete cash-flow reconciliation or a percentage of OCF. SBC is noncash and excluded. Negative amounts are excluded as reversals or net receipts; they are not converted to spending. Annual bars use reported annual amounts. Turning off a category hides its share without changing the denominator. Debt repayments prefer a reported aggregate, with long-term or convertible-only scope identified in the tooltip. Acquisitions are net of cash acquired. Dividend payments use the aggregate where reported, including dividend equivalents when part of that concept.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Market prices: Yahoo Finance · LLY, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Operating cash flow
Reported net cash provided by or used in operating activities.
Capital expenditures
Reported cash capital investment. Uses purchases of property, plant and equipment where disclosed; otherwise purchases of productive assets, which can also include software and intangibles. Excludes acquisitions and noncash lease additions.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Stock-based compensation
Reported share-based compensation addback in the cash-flow statement. Missing disclosure is not treated as zero.
SBC / free cash flow
Reported share-based compensation / (operating cash flow − cash capital investment) × 100, for the same fiscal period. Always uses FCF before SBC deduction. Zero or negative FCF is undefined; values above 100% are retained.
SBC / operating cash flow
Reported share-based compensation / reported operating cash flow × 100, for the same fiscal period. Zero or negative operating cash flow is undefined. Unaffected by the SBC deduction scenario.
Software & intangible investment
Separately tagged payments for capitalized software under US GAAP, or purchases of intangible assets under IFRS. This optional disclosure is not inferred from total capex or deducted a second time from FCF.
Diluted EPS
Reported diluted earnings per share, normalized for recorded subsequent stock splits. Quarterly EPS is never subtracted from annual or YTD EPS.